Clinica Neurologica

The trials here

What the 8 trials at this site are about, from their registry records.

Conditions

• Multiple sclerosis4 trials
• Alzheimer disease2 trials
• Mild cognitive impairment2 trials
• Depression1 trial
• Stroke1 trial

Phase

• Phase 37 trials

Status

• Active, not recruiting5 trials
• Not yet recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Hoffmann-La Roche6 trials
• Eli Lilly and Company1 trial
• Hospital Moinhos de Vento1 trial

Running trials

• Recruiting

  A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

  NCT07775300· Phase 3· Eli Lilly and Company· Source

  Contact: Alexandre Longo (principal investigator)

• Active, not recruiting

  A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

  NCT07170150· Phase 3· Hoffmann-La Roche· Source

• Not yet recruiting

  Genetic Variants in Stroke

  NCT07186517· Hospital Moinhos de Vento· Source

  Contact: Carla Moro, PhD

• Recruiting

  Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  NCT07177352· Phase 3· Hoffmann-La Roche· Source

• Active, not recruiting

  Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)

  NCT04586023· Phase 3· Hoffmann-La Roche· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)

  NCT04548999· Phase 3· Hoffmann-La Roche· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)

  NCT04544436· Phase 3· Hoffmann-La Roche· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis

  NCT04544449· Phase 3· Hoffmann-La Roche· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease1 recruiting
• Depression1 recruiting
• Mild cognitive impairment1 recruiting
• Stroke1 recruiting